DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Revlimid (Lenalidomide) - Current Clinical Trials

 
 



Revlimid Related Clinical Trials

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma [Terminated]

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer [Terminated]

A Study of Revlimid for Treatment of Non-Hodgkin's Lymphoma [Active, not recruiting]

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma [Completed]

Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL) [Active, not recruiting]

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma [Completed]

Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II [Completed]

Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma [Completed]

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas [Terminated]

Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis [Active, not recruiting]

A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer. [Terminated]

A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma [Active, not recruiting]

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma [Completed]

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer [Completed]

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 [Active, not recruiting]

Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy [Active, not recruiting]

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) [Recruiting]

Safety and Efficacy of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes Associated With a Del (5q) Cytogenetic Abnormality [Active, not recruiting]

A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)

Safety And Efficacy In Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin’s Lymphoma

Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD) [Recruiting]

Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain [Recruiting]

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes [Recruiting]

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer [Recruiting]

Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes [Completed]

Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed MM [Recruiting]

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL [Recruiting]

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma [Recruiting]

Lenalidomide for Patients With Myelofibrosis (MF) [Active, not recruiting]

Azacitidine and Lenalidomide for Acute Myeloid Leukemia [Recruiting]

The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality [Recruiting]

Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT) [Recruiting]

Lenalidomide, Lenalidomide + Azacitidine, or Standard Treatment Therapies in Newly Diagnosed Acute Myeloid Leukemia [Recruiting]

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients [Recruiting]

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Recruiting]

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma [Recruiting]

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) [Recruiting]

CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis [Completed]

Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction [Recruiting]

Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma [Active, not recruiting]

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial [Recruiting]

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) [Recruiting]

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Recruiting]

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma [Recruiting]

Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malig Who Relapse/Progress After Rituximab [Recruiting]

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia [Recruiting]

A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid [Recruiting]

Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-NaĂŻve AIPC Patients [Recruiting]

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance After Autologous Stem Cell Transplantation [Recruiting]

Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome [Recruiting]

Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients [Recruiting]

Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma

Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma [Active, not recruiting]

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors [Active, not recruiting]

A Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM) [No longer recruiting]

Safety and Efficacy of Single-Agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma [No longer recruiting]

Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome [No longer recruiting]

Phase 1 Study OF CDC-501 in Patients With Solid Tumors [No longer recruiting]

Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome [No longer recruiting]

A Multicentre, Single-Arm, Open-Label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma [Active, not recruiting]

Lenalidomide in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Did Not Respond to Treatment [Recruiting]

Lenalidomide and Prednisone in Treating Patients With Myelofibrosis [Active, not recruiting]

A Study of Oral CC-5013 (Lenalidomide; Revlimid) in Myelodysplastic Syndromes [Recruiting]

Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors [No longer recruiting]

Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL [Recruiting]

A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older [Recruiting]

Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer [Recruiting]

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme [Recruiting]

Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q- Abnormality [Recruiting]

Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma [Recruiting]

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma [Recruiting]

A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Recruiting]

Lenalidomide Plus Rituximab for Indolent Non-Hodgkin's Lymphoma [Recruiting]

Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease [Recruiting]

Maintenance Therapy Using Lenalidomide in Myeloma [Recruiting]

Lenalidomide as Initial Treatment of Patients With CLL Age 65 and Older [Recruiting]

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme [Recruiting]

Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma [Recruiting]

Study Role of Lenalidomide in Improving Sleep in CLL Patients 65+ Years Experiencing Clinically Significant Fatigue [Recruiting]

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas [Recruiting]

CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma [Completed]

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma [Recruiting]

Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [Recruiting]

Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma [Recruiting]

Dose-Finding of Lenalidomide as Maintenance in Multiple Myeloma [Not yet recruiting]

Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes [Recruiting]

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia [Recruiting]

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma [Recruiting]

An Expanded Access Program For Lenalidomide Plus Dexamethasone In Previously Treated Subjects With Multiple Myeloma [Recruiting]

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy [Recruiting]

REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas [Recruiting]

Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression [Recruiting]

Lenalidomide and Dexamethasone With/Without Transplant in Patients With Multiple Myeloma [Recruiting]

Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities [Recruiting]

Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia [Recruiting]

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS) [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012